Komori
Asakuma (7678) · RiskRestated

Supply-Chain Delays in Procurement and Logistics Due to Infectious Diseases

First written in FY2022. 3 of 4 entries say "Restated". Latest entry: FY2026.

4entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2022 – FY20262022: 120222023: 120232024: 120242025: 020252026: 12026
Same theme, other companies
Risk of COVID-19 impacts on business activities, supply chains, demand and financial performanceA theme 1295 companies write about · 1307 as a headwind · 6 as a tailwind

The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 1320 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「Restrictions on movement, lockdowns and other measures to contain infectious disease outbreaks may delay the arrival of purchased goods and the delivery of products for sale, among other effects」

    The company continues to disclose the risk of delays caused by infectious diseases across the supply chain, including procurement, logistics, production and sales destinations.
  2. FY2024RestatedAnnual report

    「Restrictions on movement, lockdowns and other measures to contain infectious disease outbreaks may delay the arrival of purchased goods and the delivery of products for sale, among other effects」

    The company continues to disclose the risk of delays caused by infectious diseases across the supply chain, including procurement, logistics, production and sales destinations.
  3. FY2023RestatedAnnual report

    「Restrictions on movement, lockdowns and other measures to contain infectious disease outbreaks may delay the arrival of purchased goods and the delivery of products for sale, potentially affecting our group's operating results or financial condition.」

    The company continues to disclose the risk of delays caused by infectious diseases across the supply chain, including suppliers, logistics providers, production plants and sales destinations.
  4. FY2022First statedAnnual report

    「Restrictions on movement, lockdowns and other measures to contain infectious disease outbreaks may delay the arrival of purchased goods and the delivery of products for sale, potentially affecting our group's operating results or financial condition.」

    The company has identified as a risk the possibility that the effects of infectious diseases could extend beyond customer demand to the entire supply chain, including suppliers, logistics providers, production plants and sales destinations.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Asakuma yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.